Lawmakers Banning Synthetic Urine Sales

Several media outlets have reported recently about a rising challenge to drug abuse management – a growing demand by individuals to purchase synthetic urine. Synthetic urine is commercially used in laboratories, research, and manufacturing of reagents. It has also been sought out by drug users seeking to defeat urine toxicology testing and can be seen in online stores, truck stops, and dispensaries. Since synthetic urine is intentionally created to have very similar properties to human urine, testing for adulterants is unhelpful in identifying its use.

As reported by the Washington Post, Fox News, and various other periodicals, some U.S. states are banning the sale and use of synthetic urine. It sounds ludicrous for those of us who use synthetic urine scientifically, but when I did my research, I found the supporting legislation. Indiana and New Hampshire have already passed laws banning synthetic urine, and Mississippi and Missouri have bills in their legislature to create the same laws. 18 states in total are moving to ban the substance. The federal government is also making moves to standardize testing that use hair and saliva instead of urine.

Will you and your team be affected if this trend of banning synthetic urine continues? Would it prevent you from using urine when testing for drugs of abuse? Do you expect that this involvement from lawmakers will increase the overall interest in oral or hair testing? Are you concerned about the false positives associated with hair samples, or the short timeframe associated with oral testing? Have you had an experience with these new laws?

I’d love to hear your stories and opinions in the comments section below.

By Danielle Ziolo

May 11 2018

Graphic by Quest Diagnostics

Lab Services: What’s Best for Your Business?

It’s all about protecting the business value of the measurement.   In previous decades, it was relatively common to simply purchasing annual contracts where the original equipment manufacturer (OEM) provided full maintenance services for its products. However, as instruments became more reliable and cost reduction mandates swept through labs, the situation became more complicated as managers began to seek less costly alternatives.  Read More…

CMS Wants Your Opinion on Regulations

“The CMS is taking a hard look at whether regulations governing clinical laboratories need to be updated. Industry groups hailed the move, which they say is long overdue…”

“The CMS posted a request for information on Friday asking the industry for input on how the policies should be updated. Specifically, the agency is interested in whether personnel requirements, testing standards and industry fee structures need to be updated.”

Read More…

 

ZC @ MSACL

Our first conference of the year is MSACL (Mass Spectrometry: Applications to the Clinical Laboratory) in Palm Springs, California. We are looking forward to meeting new people and learning from other experts in the field.

Come and visit us at booth 34 for your chance to win great prizes!

Check out the website for MSACL at: https://www.msacl.org/index.php

A Year to Shine and Share

Happy New Year Everyone!

Join us in a new endeavor as we begin an active blog, filled with ZC Family fun, important healthcare news stories, medical discovers and innovations, and new offers from Zephyr the Chameleon.

Also, sign up for our monthly newsletter to keep up-to-date on changes to industry regulations, tips and pointers for your healthcare business, and featured stories and articles relevant to your success.

We at Ziolo Consulting are excited for the new opportunities awaiting us and the ZC family. We can’t wait to share in the adventure with you!

Ziolo Consulting at AACC

Ziolo Consulting attended the American Association of Clinical Chemistry Conference this year in Philadelphia PA. CEO Danielle McDonald, and Vice President Glen Ziolo enjoyed several classes and lectures offered.  Some of those classes include: “Technologies that Could Change the Future of Clinical Chemistry” and “The Next Frontier in Precision Medicine – Targeted Peptide Diagnostic Mass Spectrometry Assays”. They also toured the booths at the Expo and connected with several of the companies that made advances in technology that could change the future of LC-MS labs. “We both had a great time and met so many great people working in our field.  We look forward to bringing these technologies and connections to better service our clients now and in the future.”

-Written by Glen Ziolo